- /
- Supported exchanges
- / US
- / HBIO.NASDAQ
Harvard Bioscience Inc (HBIO NASDAQ) stock market data APIs
Harvard Bioscience Inc Financial Data Overview
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Harvard Bioscience Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Harvard Bioscience Inc data using free add-ons & libraries
Get Harvard Bioscience Inc Fundamental Data
Harvard Bioscience Inc Fundamental data includes:
- Net Revenue: 86 550 K
- EBITDA: 7 443 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-05
- EPS/Forecast: 0.04
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Harvard Bioscience Inc News
New
Harvard Bioscience, Inc. Q4 2025 Earnings Call Summary
Harvard Bioscience, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Evolution and Operational Foundation Management characterized 2025 as a pivotal foundation-building year, focusing on improvin...
Harvard Bioscience (HBIO) Earnings Transcript
Image source: The Motley Fool. DATE Mar. 12, 2026 at 8 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — John Duke Chief Financial Officer — Mark Frost Need a quote from a Mot...
Harvard Bioscience Sets 1-for-10 Reverse Stock Split; Shares Drop 12% Overnight
(RTTNews) - Harvard Bioscience, Inc. (HBIO), a provider of specialized life-science research instruments, announced for a 1-for-10 reverse stock split that will take effect on March 13, 2026, with spl...
Harvard Bioscience Announces Reverse Stock Split
Harvard Bioscience, Inc. Harvard Bioscience’s common stock is expected to begin trading on a post-split adjusted basis on March 16, 2026 HOLLISTON, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Harvar...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.